Scholarlink

Background <p>Vitamin B12 deficiency is a common but under-recognized comorbidity among HIV-infected individuals, contributing to anemia, neurological impairment, and poor immune recovery. In sub-Saharan Africa, where HIV burden is high, routine screening for B12 deficiency is rarely performed, and data in Uganda are scarce. This study aimed to determine the prevalence of vitamin B12 deficiency, identify associated factors, and examine its correlation with CD4 count among HIV-positive adults.</p> Methods <p>We conducted a cross-sectional study among 156 HIV-positive adults at Kayunga Regional Referral Hospital, Uganda. Serum vitamin B12 was measured using the ARCHITECT B12 assay. Deficiency was defined as &lt; 200 pg/mL. Logistic regression and Spearman correlation were used to identify predictors and assess relationships with CD4 counts.</p> Results <p>Vitamin B12 deficiency was present in 25% of participants. Significant independent predictors included: low income (aOR 2.5, 95% CI 1.07–5.75), ART-naïve status (aOR 2.9, 95% CI 1.03–8.73), underweight BMI (aOR 4.2, 95% CI 1.89–9.60), and HIV duration &gt; 10 years (aOR 4.0, 95% CI 1.32–12.1). CD4 count showed a modest inverse correlation (ρ = −&#xa0;0.24, <i>p</i> &lt; 0.001).</p> Conclusion <p>Vitamin B12 deficiency is prevalent among HIV-positive adults in Uganda. Routine screening and nutritional interventions are recommended, especially for high-risk groups.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Prevalence of vitamin B12 deficiency, associated factors, and correlation with CD4 count among HIV-positive adults at Kayunga Regional Referral Hospital, Central Uganda

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月29日

查看全文
  • Mohamed Jayte,
  • Mai Abdalla Ali,
  • Abdifatah Hersi Karshe,
  • Abdifitah Abdullahi Mohamed,
  • Farah Dubad Abdi,
  • Yahye Mohamed Jama,
  • Theoneste Hakizimana,
  • Awil Abdulkadir Abdi,
  • Abukar Ali Ahmed,
  • Abishir Mohamud Hirsi

摘要

Background

Vitamin B12 deficiency is a common but under-recognized comorbidity among HIV-infected individuals, contributing to anemia, neurological impairment, and poor immune recovery. In sub-Saharan Africa, where HIV burden is high, routine screening for B12 deficiency is rarely performed, and data in Uganda are scarce. This study aimed to determine the prevalence of vitamin B12 deficiency, identify associated factors, and examine its correlation with CD4 count among HIV-positive adults.

Methods

We conducted a cross-sectional study among 156 HIV-positive adults at Kayunga Regional Referral Hospital, Uganda. Serum vitamin B12 was measured using the ARCHITECT B12 assay. Deficiency was defined as < 200 pg/mL. Logistic regression and Spearman correlation were used to identify predictors and assess relationships with CD4 counts.

Results

Vitamin B12 deficiency was present in 25% of participants. Significant independent predictors included: low income (aOR 2.5, 95% CI 1.07–5.75), ART-naïve status (aOR 2.9, 95% CI 1.03–8.73), underweight BMI (aOR 4.2, 95% CI 1.89–9.60), and HIV duration > 10 years (aOR 4.0, 95% CI 1.32–12.1). CD4 count showed a modest inverse correlation (ρ = − 0.24, p < 0.001).

Conclusion

Vitamin B12 deficiency is prevalent among HIV-positive adults in Uganda. Routine screening and nutritional interventions are recommended, especially for high-risk groups.